Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2681 |
|
Actual shortage: | 250 (9%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2422 (90%) | |
Discontinuation Reports |
250 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 247 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
25 (10%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-CYPROTERONE / ETHINYL ESTRADIOL | 0.035MG 2MG | TABLET | Resolved | 2021-04-29 | 2021-09-02 | 138297 |
TEVA-SUCRALFATE | 1G | TABLET | Resolved | 2021-04-29 | 2021-05-13 | 138300 |
TEVA-CAPTOPRIL | 50MG | TABLET | Resolved | 2021-04-29 | 2021-05-06 | 138303 |
TEVA-LOSARTAN | 25MG | TABLET | Resolved | 2021-04-29 | 2024-04-01 | 138306 |
TEVA-LOSARTAN | 50MG | TABLET | Resolved | 2021-04-29 | 2021-05-20 | 138309 |
TEVA-LOSARTAN | 100MG | TABLET | Resolved | 2021-04-29 | 2021-05-20 | 138312 |
TEVA-HALOPERIDOL | 5MG | TABLET | Resolved | 2021-04-29 | 2021-06-10 | 138317 |
TEVA-SUMATRIPTAN DF | 50MG | TABLET | Resolved | 2021-04-29 | 2021-08-24 | 138320 |
TEVA-LACOSAMIDE | 50MG | TABLET | Resolved | 2021-04-29 | 2021-06-24 | 138323 |
TEVA-ROSUVASTATIN | 40MG | TABLET | Resolved | 2021-05-06 | 2021-06-03 | 138907 |
TEVA-TADALAFIL | 5MG | TABLET | Resolved | 2021-05-06 | 2021-05-27 | 138910 |
ACT ENALAPRIL | 2MG | TABLET | Resolved | 2021-05-13 | 2021-05-20 | 139297 |
TEVA-EZETIMIBE | 10MG | TABLET | Resolved | 2021-05-13 | 2021-09-02 | 139300 |
TEVA-LOSARTAN | 25MG | TABLET | Resolved | 2021-05-13 | 2021-05-20 | 139306 |
TEVA-ROSUVASTATIN | 40MG | TABLET | Resolved | 2021-05-13 | 2022-03-18 | 139309 |
TEVA-BUPRENORPHINE/NALOXONE | 2MG 0.5MG | TABLET | Resolved | 2021-05-20 | 2021-06-03 | 139725 |
TEVA-CARBAMAZEPINE | 200MG | TABLET | Resolved | 2021-05-20 | 2021-05-27 | 139728 |
TEVA-PRAVASTATIN | 40MG | TABLET | Resolved | 2021-05-20 | 2021-08-13 | 139737 |
TEVA-RISPERIDONE | 3.0MG | TABLET | Resolved | 2021-05-20 | 2021-06-03 | 139743 |
TEVA-RISPERIDONE | 4.0MG | TABLET | Resolved | 2021-05-20 | 2021-07-09 | 139746 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
DOCETAXEL INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63937 | ||
DOCETAXEL INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63940 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-12 | 2018-10-12 | 63952 | ||
GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63967 | ||
GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63970 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64520 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64526 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64529 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64532 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64535 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64544 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64547 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64550 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64553 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64589 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64592 | ||
RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64595 | ||
RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64598 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64615 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64623 |